CoQ10 doesn’t appear to improve implantation directly, but it does improve the quality of eggs before they’re fertilized, which is one of the biggest factors determining whether an embryo successfully implants. A 2020 meta-analysis of randomized controlled trials found that women who took CoQ10 had clinical pregnancy rates of 28.8% compared to 14.1% in those who took a placebo. The effect is indirect: CoQ10 works months before implantation happens, during the window when eggs are maturing inside the ovary.
How CoQ10 Supports Egg Quality
Eggs are among the most energy-hungry cells in the body. Unlike most cells, which can switch between different fuel sources, eggs rely almost entirely on their mitochondria to produce energy. CoQ10 is a critical part of this energy-production chain. It sits inside the mitochondrial membrane and shuttles electrons between protein complexes, a step that’s essential for generating ATP, the cell’s energy currency.
That energy powers everything an egg needs to do before and after fertilization: completing its final stages of maturation, assembling the spindle structure that divides chromosomes correctly, and sustaining the early embryo through its first days of development before it reaches the uterus. Research published in Cell Reports showed that when CoQ10 production drops in eggs (as it does with age), the result is reduced ATP levels, more chromosome-sorting errors, and compromised embryo development. All of those problems make successful implantation less likely, even if the uterine lining is perfectly receptive.
What the Clinical Evidence Shows
A systematic review and meta-analysis in the Journal of Assisted Reproduction and Genetics pooled data from randomized controlled trials of women undergoing IVF. Overall, CoQ10 supplementation roughly doubled the odds of clinical pregnancy. The strongest results appeared in women with PCOS, where pregnancy rates were 31.3% with CoQ10 versus 7.5% without. Women with diminished ovarian reserve also saw improvement, with pregnancy rates of 27.3% compared to 17.5% in controls.
However, when researchers looked specifically at implantation rate per embryo transferred, the picture was less clear. One study in women with poor ovarian response found no significant difference in implantation rates (26.2% vs. 21.4%). A 2024 meta-analysis similarly noted there wasn’t enough data across studies to pool implantation rates as a standalone outcome. This suggests CoQ10’s main benefit is producing better embryos in the first place rather than enhancing what happens after transfer.
A separate review in the International Journal of Molecular Sciences struck a more cautious note, concluding that while the biological rationale is strong, the available human data “do not clearly prove its ability to improve human oocyte quality.” The studies so far have been relatively small, and some used CoQ10 alongside other supplements, making it hard to isolate its individual effect.
CoQ10 Does Not Thicken the Uterine Lining
If you’re wondering whether CoQ10 helps prepare the uterus itself for implantation, the answer appears to be no. A 2024 meta-analysis of three studies involving 349 women found no significant improvement in endometrial thickness among women who took CoQ10 before their IVF cycle. CoQ10’s benefits are concentrated on the egg and embryo side of the equation, not on uterine receptivity.
Who Benefits Most
The research consistently points to two groups that see the clearest gains from CoQ10 supplementation. Women with diminished ovarian reserve, a condition where fewer eggs remain and their quality tends to be lower, showed meaningfully higher pregnancy rates in multiple trials. Women with PCOS showed even more dramatic improvements, with one pooled analysis finding more than five times the odds of pregnancy compared to controls.
Age plays an important role in who responds. As women get older, the enzymes responsible for producing CoQ10 inside egg cells become less active. This decline has been documented in both mouse and human eggs. One subgroup analysis found that women under 35 with diminished ovarian reserve were the most likely to benefit, possibly because their eggs still have enough underlying potential to respond to the energy boost. For women with normal ovarian reserve undergoing standard IVF, the evidence of benefit is thinner.
Dosage and Timing
Most fertility studies have used 200 mg three times daily (600 mg total per day), taken for at least 60 days before ovarian stimulation begins. For women with normal ovarian reserve, a lower dose of 200 mg per day for 30 to 35 days before stimulation has been used. One meta-analysis found that three months of supplementation before a treatment cycle was optimal, which aligns with biology: it takes roughly 85 days for a primary follicle to mature into an ovulation-ready egg. Starting CoQ10 at least three months out gives it time to influence the full maturation window.
Interestingly, one subgroup analysis found that even a lower dose of 30 mg per day for three months improved clinical pregnancy rates, suggesting that duration may matter as much as dose. If you’re planning a frozen embryo transfer or a natural conception cycle, the same three-month lead time applies.
Ubiquinol vs. Ubiquinone
CoQ10 supplements come in two forms. Ubiquinone is the oxidized form and has been used in most fertility research. Ubiquinol is the reduced, active form. A four-week absorption trial found that 200 mg of ubiquinol per day was 70% more bioavailable than the same dose of ubiquinone, meaning more of it reaches the bloodstream. Ubiquinol is more efficiently absorbed during digestion and transported across the intestinal wall.
Some newer fertility studies have used ubiquinol specifically. In one trial of women with PCOS who weren’t responding to standard ovulation medication, 100 mg per day of ubiquinol improved ovarian responsiveness enough to match the results of injectable hormone therapy. Because of its better absorption, ubiquinol may allow you to take a lower dose and achieve similar tissue levels, though head-to-head fertility trials comparing the two forms are still limited.
Safety During Pregnancy
CoQ10 is generally well tolerated as a preconception supplement, but there is no established consensus on its safety once pregnancy begins. The Mayo Clinic notes that healthcare professionals have not determined whether CoQ10 is safe during pregnancy or breastfeeding. Most fertility protocols call for taking it during the months leading up to conception or embryo transfer, not continuing it afterward. If you get a positive pregnancy test while taking CoQ10, raise it with your care team so they can advise on whether to continue or stop.